On December 11, 2009 , WADA, in collaboration with the Monitoring Group of the Anti-Doping Convention of the Council of Europe organized a TUEC Chair Symposium in Strasbourg, France. This followed the previous success of the first Symposium held in 2006 in Bonn, Germany.

This Symposium allowed exchange of knowledge between experts in order to establish consistency in the TUE decision-making process and addressed a range of issues related to TUEs. including the revised International Standard for TUE; the introduction of fresh medical information; case studies from selected physicians involved in National Anti-Doping Organizations (NADOs) and International Federations (IFs); as well as legal and ethical aspects of TUEs.

More than 145 experts participated in the Symposium. Sixty NADOs and 43 IFs were represented at the meeting.

Presentations are available by clicking on the links below.

Session 1: The International Standard for TUEs

2009 Experience - Testimonial - UKAD
UK Sports

2009 Experience - Testimonial - NADA
NADA

TUE Screening Process - Lessons to be learned
Dr. P. Jenoure

Changes of 2010 Prohibited List and effect on ISTUE
Dr. M. Petrou

Session 2: The Challenging Role of the TUEC – Presentation of interesting cases

Case Study 1 - Asthma
Dr. D. Constantinou (SAIDS)

Case Study 2 - Use of Beta-blockers
Dr. A. Bauer (FITA)

Case Study 3 - Use of GCS
Pr. A. Pipe (FINA)

Case Study 4 - TUE Management for IPC
Dr. O. Martinez (IPC)

Case Study 5 - ADHD
Pr. A. Eichner (USADA)

Session 3: WADA’s Medical Information to Support the Decisions of TUECs

Medical Information - Infertility
Dr. M. Mountjoy

Medical Information - IV Infusion
Pr. D. Gerrard

Medical Information - Asthma
Pr. K-Y. Kim

PRP in the light of 2010 Prohibited List
Dr. P. Jenoure

Reintroduction of Pseudoephedrine to 2010 Prohibited List
Dr. A. Vernec

Session 4: Legal Perspectives of TUE

Legal Perspectives - TUE Applications and Declaration of Use
Pr. U. Haas

Legal Perspectives - Results Management of AAFs involving TUEs
Pr. L. Horta